期刊文献+

云南宣威昆明两地肺癌ras基因表达的异质性研究

Genetic heterogeneity of expression of Ras gene in patients with non-small-cell lung cancer of Xuanwei and Kunming
下载PDF
导出
摘要 目的云南省宣威市是我国的肺癌高发地区,具有显著的地域性特点,本研究通过比较ras基因在宣威及昆明两地肺癌中表达的差异性,分析ras基因在两地肺癌中的异质性。方法采用免疫组化染色技术,对45例宣威地区肺癌和45例昆明地区肺癌石蜡包埋组织标本中ras基因的表达进行检测,比较ras基因在两组肺癌组织中表达的差异。结果90例肺癌组织中55例ras基因表达阳性,其中宣威肺癌组31例,昆明肺癌组24例,两组相比,差异无统计学意义(62.0%vs48.0%,χ2=2.291,P=0.130)。ras基因在宣威肺腺癌病例中的阳性表达率为78.3%(19/23),在昆明肺腺癌病例中为47.8%(11/23),宣威肺癌组高于昆明肺癌组,差异有统计学意义(78.3%vs47.8%,χ2=4.572,P=0.032)。结论ras基因在两地肺腺癌病例中的表达存在着差异性,提示ras基因在两地肺腺癌中存在着异质性。 Objective To compare the differences of ras gene expression and genetic heterogeneity in non-small-cell lung cancer (NSCLC) between in Xuanwei and in Kunming. Methods Samples of paraffin-embedded lung cancer tissues of 45 patients from Xuanwei and 45 patients from Kunming with NSCLC underwent radical resection were analyzed for expression of ras protein by imrnunohistochemical staining. The difference of ras protein expression between two groups was compared. Results Among these 90 cases, 55cases had ras protein expression. Comparing the expressions of ras protein in two groups, statistically significant difference between two groups in terms of expression of ras protein in cases with adenocarcinoma was found(78.3% vs 47.8%, X 2=4.572, P=0.032). Conclusion These data suggest that there is statistically significant difference in ras protein expression in patients with adenocarcinoma of lung between two groups, which means there is genetic heterogeneity of ras in adenocarcinomas of lung between Xuanwei and Kunming.
出处 《云南医药》 CAS 2009年第6期608-610,共3页 Medicine and Pharmacy of Yunnan
基金 云南省自然科学基金(NO.2002C0010R)
关键词 RAS基因 异质性 非小细胞肺癌 Genetic heterogeneity Ras gene Non-small cell lung cancer
  • 相关文献

参考文献6

  • 1NAGAI Y,MIYAZAWA H. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp[J].Cancer Res, 2005, 65(16):7276-7282.
  • 2金永堂,周晓铁,何兴舟.宣威肺癌遗传因素作用大小的估算与分析[J].中国肺癌杂志,2001,4(5):354-356. 被引量:8
  • 3MARSHALL WA,STEVEN HR, MING Y, et al. Role of proto-oncogene activation in carcinogenesis [J]. Environ Health Perspect, 1992, 98(1 ): 12-19.
  • 4MULSHINE JL, TRESTON AM, BROWN PH, et al. Initiators and promoters of lung cancer [J]. Chest, 1993,103 (Suppl): 4-12.
  • 5FENG Z, HU W, CHEN JX, et at. Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer [J].J Natl Cancer Inst, 2002, 94 (20): 1527-1535.
  • 6OKAMURA M, MOTO M, KASHIDA N, et al.Carcinogenic susceptibility to N-his (2-hydroxypropyl) nitrosamine (DHPN) in rasH2 mice [J]. Toxieol Pathol, 2004, 32 (4): 474-481.

二级参考文献5

  • 1实用肿瘤学编委会.实用肿瘤学(第一册)[M].北京:人民卫生出版社,1978.107-145.
  • 2张师鲁.流行病学进展(第3卷)[M].北京:人民卫生出版社,1983.8-21.
  • 3刘支援 何兴舟.宣威肺癌高发的病因学研究[J].中华流行病学杂志,1986,11(2):79-81.
  • 4金永堂,何兴舟.肺癌流行的遗传因素研究进展[J].国外医学(卫生学分册),1991,18(1):25-28. 被引量:4
  • 5刘祖洞,李璞.阈值性状的遗传率[J].国际遗传学杂志,1984,27(2):57-73. 被引量:12

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部